ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1209

Starting Time Of Inflammatory Attacks In Patients With Familial Mediterranean Fever

Feyza Berktas1, Nilufer Alpay Kanitez1, Bahtiyar Toz1, Oguz Kaan Bakkaloglu1, Burak Erer2 and Ahmet Gul1, 1Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Internal Medicine, Rheumatology Division, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, Familial Mediterranean fever, inflammation and innate immunity

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases I: Autoinflammatory Syndromes

Session Type: Abstract Submissions (ACR)

Background/Purpose: Familial Mediterranean fever (FMF), the most common form of the hereditary autoinflammatory diseases, is characterized by recurrent self-limiting attacks of fever and/or serositis accompanied with acute phase response. Recurrence of attacks does not show a clear periodicity, and its timing is usually unpredictable. Little is known about the factors triggering or precipitating the attacks, and some patients describe physical or emotional exertion, menstrual cycle and dietary changes as possible triggers of the attacks. In other hereditary autoinflammatory disorders, a diurnal variation for the attack was observed with a tendency to experience attacks during evening or night. Recent data suggest that expression of some genes may show a circadian rhythm and affect the immune system, especially innate immune response. In this study, we aim to collect data retrospectively from FMF patients about the starting time of their attacks.

Methods: As a pilot study, we did a questionnaire based survey in 199 consecutive adult FMF patients. All patients fulfilled the Tel-Hashomer criteria for the diagnosis of FMF, and experienced attack(s) during the last year. All patients were interviewed directly or by telephone contacts to answer the questionnaire items about their attacks. The list of questions included usual start time of attacks during the day, their attack frequency, severity and possible triggers (such as sleeplessness, hunger, tiredness, stress, diet, medications, other diseases, menstruation and cold exposure) of the attacks during the past year.

Results: All patients (n=199) agreed to participate in the study and provided answers to the questions. Their mean age was 35.7 and sixty-two (61%) were female. The most commonly reported attack triggering factors were emotional stress (61%), tiredness (57%), menstruation (42% of female patients), followed by dietary changes (18%), cold exposure (5%), sleeplessness (18%) and hunger (3%). Only 9 patients (4%) had an occupation with night shifts. In all group, 63% of the patients provided a definite answer to the question about starting time of attacks. The majority reported that of their attacks started in the evening (41.3%), and less frequently in the morning (28.6%), at night (17.4%) and in the afternoon (12.7%). There was no correlation between the start time of the attacks and triggering factors or night shifts.  

Conclusion: This questionnaire-based retrospective survey suggests that starting time of FMF attacks have a tendency for evening. This information may provide some clues about circadian changes affecting the FMF-related inflammation and the threshold for attack development, after its confirmation with prospective data collection.


Disclosure:

F. Berktas,
None;

N. Alpay Kanitez,
None;

B. Toz,
None;

O. K. Bakkaloglu,
None;

B. Erer,
None;

A. Gul,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/starting-time-of-inflammatory-attacks-in-patients-with-familial-mediterranean-fever/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology